IODINE (124I) GIRENTUXIMAB

Search structure
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms Phase 3 ClinicalTrials
CONTENTS